Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle.

  • Published 1988 in The New England journal of medicine


We studied the timing and duration of adjuvant chemotherapy for operable breast cancer with axillary-node involvement in a randomized trial including 1229 patients divided into three treatment groups. One group received a single perioperative course of adjuvant combination chemotherapy beginning within 36 hours of mastectomy; a second received six cycles of… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.